Trafficking protein particle complex subunit 1 (30-38)

Trafficking protein particle complex subunit 1 (30-38) is a synthetic peptide fragment derived from the TRAPPC1 protein, which is a core component of the transport protein particle (TRAPP) complex involved in intracellular vesicle trafficking. As a segment corresponding to amino acids 30 through 38 of TRAPPC1, this peptide provides a valuable research tool for investigating the molecular mechanisms underlying vesicle transport, membrane trafficking, and protein-protein interactions within eukaryotic cells. Its defined sequence and origin make it particularly relevant for studies focused on dissecting the functional domains of TRAPPC1 and their roles in the assembly and regulation of the TRAPP complex.

Peptide mapping: The TRAPPC1 (30-38) peptide serves as a precise probe for peptide mapping experiments aimed at elucidating the structural and functional domains of the TRAPPC1 protein. By enabling targeted analysis of this specific region, researchers can investigate how the 30-38 amino acid segment contributes to the overall architecture and interaction profile of TRAPPC1 within the TRAPP complex. Such studies are instrumental in identifying critical residues involved in complex assembly and stability, thereby advancing understanding of vesicle tethering mechanisms.

Protein-protein interaction studies: The 30-38 fragment of TRAPPC1 is highly suitable for in vitro binding assays designed to characterize interactions between TRAPPC1 and other TRAPP subunits or accessory factors. By employing this peptide in pull-down, surface plasmon resonance, or co-immunoprecipitation assays, scientists can delineate the contribution of the 30-38 region to specific binding events. These insights facilitate the mapping of contact sites essential for complex formation and may help distinguish direct interactions from those mediated by other domains.

Antibody generation and epitope characterization: As a well-defined peptide antigen, TRAPPC1 (30-38) can be used to generate site-specific antibodies targeting the corresponding region of the native protein. Such antibodies are valuable for applications including Western blotting, immunoprecipitation, and immunofluorescence, where precise recognition of TRAPPC1 is required. Additionally, the peptide enables epitope mapping studies, supporting the identification and validation of antibody binding sites within the TRAPPC1 sequence.

Post-translational modification analysis: The synthetic peptide representing amino acids 30-38 of TRAPPC1 offers a controlled substrate for investigating potential post-translational modifications (PTMs) such as phosphorylation, acetylation, or methylation. In vitro modification assays using this peptide allow researchers to assess the susceptibility of the 30-38 region to specific enzymes and to characterize the functional impact of such modifications on protein-protein interactions or complex assembly. This approach aids in unraveling regulatory mechanisms that modulate TRAPPC1 function.

Mass spectrometry standards: Due to its defined sequence and purity, the TRAPPC1 (30-38) peptide is well-suited as a reference standard or internal calibrant in mass spectrometry-based proteomics workflows. It can be used to optimize peptide detection, quantify TRAPPC1-derived peptides in complex samples, and validate peptide identification in targeted or discovery proteomics experiments. Employing this peptide as a standard enhances analytical accuracy and supports robust quantification of TRAPPC1 expression and modification states in cellular or biochemical studies.

1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists